Incidence, mortality, and economic burden of myasthenia gravis in China: A nationwide population-based study

Jingshan CHEN; De-Cai Tian; Chao Zhang; Yi Zhai; Yuwen Xiu; Hongqiu Gu; Hao Li; Yongjun Wang; Fu-Dong Shi

doi:10.1016/j.lanwpc.2020.100063

journal article Open Access Dec 01, 2020

Incidence, mortality, and economic burden of myasthenia gravis in China: A nationwide population-based study

Jingshan CHEN De-Cai Tian Chao Zhang

Yi Zhai Yuwen Xiu Hongqiu Gu Hao Li

Yongjun Wang

Fu-Dong Shi

The Lancet Regional Health - Western Pacific Vol. 5 pp. 100063 · Elsevier BV

View at Publisher Save 10.1016/j.lanwpc.2020.100063

Topics

No keywords indexed for this article. Browse by subject →

References

38

[1]

Myasthenia Gravis

Nils E. Gilhus

New England Journal of Medicine 2016 10.1056/nejmra1602678

[2]

Gilhus "Myasthenia gravis: subgroup classification and therapeutic strategies" Lancet Neurol (2015) 10.1016/s1474-4422(15)00145-3

[3]

Meriggioli "Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity" Lancet Neurol (2009) 10.1016/s1474-4422(09)70063-8

[4]

Deenen "The epidemiology of neuromuscular disorders: a comprehensive overview of the literature" J Neuromuscul Dis (2015) 10.3233/jnd-140045

[5]

Gattellari "A national epidemiological study of myasthenia gravis in Australia" Eur J Neurol (2012) 10.1111/j.1468-1331.2012.03698.x

[6]

Matsui "Increasing incidence of elderly onset patients with myasthenia gravis in a local area of Japan" J Neurol Neurosurg Psychiatry (2009) 10.1136/jnnp.2008.152637

[7]

Lee "The epidemiology of myasthenia gravis in Korea" Yonsei Med J (2016) 10.3349/ymj.2016.57.2.419

[8]

Jiang "Achieving best outcomes for patients with cardiovascular disease in China by enhancing the quality of medical care and establishing a learning health-care system" Lancet (2015) 10.1016/s0140-6736(15)00343-8

[9]

Liew "Comparison of plasmapheresis and intravenous immunoglobulin as maintenance therapies for juvenile myasthenia gravis" JAMA Neurol (2014) 10.1001/jamaneurol.2014.17

[10]

Zhang "Immunotherapy choice and maintenance for generalized myasthenia gravis in China" CNS Neurosci Ther (2020) 10.1111/cns.13468

[11]

McGrogan "The incidence of myasthenia gravis: a systematic literature review" Neuroepidemiology (2010) 10.1159/000279334

[12]

Mombaur "Incidence of acetylcholine receptor-antibody-positive myasthenia gravis in South Africa" Muscle Nerve (2015) 10.1002/mus.24348

[13]

Parr "How common is childhood myasthenia? The UK incidence and prevalence of autoimmune and congenital myasthenia" Arch Dis Child (2014) 10.1136/archdischild-2013-304788

[14]

Pedersen "Late-onset myasthenia not on the increase: a nationwide register study in Denmark, 1996–2009" Eur J Neurol (2013) 10.1111/j.1468-1331.2012.03850.x

[15]

VanderPluym "Clinical characteristics of pediatric myasthenia: a surveillance study" Pediatrics (2013) 10.1542/peds.2013-0814

[16]

Popperud "Juvenile myasthenia gravis in Norway: a nationwide epidemiological study" Eur J Paediatr Neurol (2017) 10.1016/j.ejpn.2016.09.001

[17]

Andersen "Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries" Acta Neurol Scand Suppl (2014) 10.1111/ane.12233

[18]

Carr "A systematic review of population based epidemiological studies in myasthenia gravis" BMC Neurol (2010) 10.1186/1471-2377-10-46

[19]

Myasthenia Gravis in the Elderly

Johan A. Aarli

Annals of the New York Academy of Sciences 2008 10.1196/annals.1405.040

[20]

Aarli "Late-onset myasthenia gravis: a changing scene" Arch Neurol (1999) 10.1001/archneur.56.1.25

[21]

Cortes-Vicente "Clinical and therapeutic features of myasthenia gravis in adults based on age at onset" Neurology (2020) 10.1212/wnl.0000000000008903

[22]

Casetta "Myasthenia gravis: a changing pattern of incidence" J Neurol (2010) 10.1007/s00415-010-5651-z

[23]

Omorodion "Inpatient cost analysis for treatment of myasthenia gravis" Muscle Nerve (2017) 10.1002/mus.25624

[24]

Gilhus "Myasthenia gravis and risks for comorbidity" Eur J Neurol (2015) 10.1111/ene.12599

[25]

Wakata "Myasthenia gravis and diabetes mellitus: a 35-year retrospective study" Intern Med (2007) 10.2169/internalmedicine.46.6237

[26]

Misra "A study of comorbidities in myasthenia gravis" Acta Neurol Belg (2020) 10.1007/s13760-019-01102-w

[27]

Oh "Statins may aggravate myasthenia gravis" Muscle Nerve (2008) 10.1002/mus.21074

[28]

Tannemaat "Emerging therapies for autoimmune myasthenia gravis: towards treatment without corticosteroids" Neuromuscul Disord (2020) 10.1016/j.nmd.2019.12.003

[29]

Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease

Li Wei, Thomas M. MacDonald, Brian R. Walker

Annals of Internal Medicine 2004 10.7326/0003-4819-141-10-200411160-00007

[30]

The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis

Camille Roubille, Vincent Richer, Tara Starnino et al.

Annals of the Rheumatic Diseases 2015 10.1136/annrheumdis-2014-206624

[31]

Vincent "Myasthenia gravis" Lancet (2001) 10.1016/s0140-6736(00)05186-2

[32]

Marx "The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes" Autoimmun Rev (2013) 10.1016/j.autrev.2013.03.007

[33]

Tsinzerling "Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology" J Neurol Neurosurg Psychiatry (2007) 10.1136/jnnp.2006.109488

[34]

Neumann "Myasthenic crisis demanding mechanical ventilation: a multicenter analysis of 250 cases" Neurology (2020) 10.1212/wnl.0000000000008688

[35]

Myasthenic crisis

C. E. Thomas, Stephan Mayer, Y. Gungor et al.

Neurology 1997 10.1212/wnl.48.5.1253

[36]

Alshekhlee "Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals" Neurology (2009) 10.1212/wnl.0b013e3181a41211

[37]

Owe "Causes of death among patients with myasthenia gravis in Norway between 1951 and 2001" J Neurol Neurosurg Psychiatry (2006) 10.1136/jnnp.2005.072355

[38]

Zhang "Clinical and serological study of myasthenia gravis in HuBei Province, China" J Neurol Neurosurg Psychiatry (2007) 10.1136/jnnp.2006.100545

Cited By

86

Successful prehospital resuscitation of a young female patient with myasthenia gravis experiencing cardiopulmonary arrest due to complete airway obstruction: a case report and review of the literature

Ziliang Ruan, Tao Wang · 2026

Journal of Medical Case Reports

Therapeutic Plasma Exchange in AChR-Ab Positive Generalized Myasthenia Gravis: A Real World Study About Its Early Response

Jiaxin Chen, Li Feng · 2024

Journal of Inflammation Research

Therapeutic Effects of Batoclimab in Chinese Patients with Generalized Myasthenia Gravis: A Double-Blinded, Randomized, Placebo-Controlled Phase II Study

Chong Yan, Rui-Sheng Duan · 2022

Neurology and Therapy

Efficacy and Safety of Tacrolimus Therapy for a Single Chinese Cohort With Very-Late-Onset Myasthenia Gravis

Yiming Zheng, Xiaoqiu Yuan · 2022

Frontiers in Neurology

Metrics

86

Citations

38

References

Details

Published: Dec 01, 2020
Vol/Issue: 5
Pages: 100063
License: View

Authors

Department of Chemistry and E. O. Lawrence Berkeley National Laboratory, University of California, Berkeley, CA 94720

Y

Yi Zhai

Experimental Center for Science and Technology, Nanjing University of Chinese Medicine, Nanjing, China

NEC Research Institute, 4 Independence Way, Princeton, NJ 08540, USA.

Y

Yongjun Wang

Science and Technology on Vacuum Technology and Physics Laboratory, Lanzhou Institute of Physics, China Academy of Space Technology, Lanzhou 730000, China.

F

Fu-Dong Shi

Cite This Article

Jingshan CHEN, De-Cai Tian, Chao Zhang, et al. (2020). Incidence, mortality, and economic burden of myasthenia gravis in China: A nationwide population-based study. The Lancet Regional Health - Western Pacific, 5, 100063. https://doi.org/10.1016/j.lanwpc.2020.100063

Incidence, mortality, and economic burden of myasthenia gravis in China: A nationwide population-based study

You May Also Like